THE HARPLE GROUP, LLC

Lobbying for ELI LILLY & COMPANY · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · $10,000.00 income · posted Jan 15, 2026

Lobbying activity 1

Health Issues

Monitored Issues and advised clients on matters related to Pharmaceutical supply chain security and resiliency.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.